Glucose Health (OTCMKTS:GLUC – Get Free Report) released its quarterly earnings results on Monday. The company reported ($0.01) EPS for the quarter, Zacks reports. The business had revenue of $0.05 million during the quarter.
Glucose Health Price Performance
Shares of GLUC remained flat at $0.30 during mid-day trading on Wednesday. 27,300 shares of the stock traded hands, compared to its average volume of 18,329. Glucose Health has a 12-month low of $0.13 and a 12-month high of $0.67. The company has a market capitalization of $8.54 million, a P/E ratio of -10.00 and a beta of 1.30. The firm’s fifty day simple moving average is $0.36 and its 200 day simple moving average is $0.36.
Top Glucose Health Stories
Here are a few of the latest stories about GLUC:
- Neutral Sentiment: Recent coverage discussed blood-sugar-friendly food choices, diabetes awareness, and patients’ rights over health data. These stories reflect attention to the broader diabetes category but do not report developments specific to Glucose Health. Article: Breakfast swaps to curb blood sugar crashes Article: Charter on diabetes health data
- Negative Sentiment: Glucose Health reported earnings per share of -$0.01 and quarterly revenue of just $0.05 million. The loss and small revenue base highlight the company’s limited current financial scale and could pressure the stock. Glucose Health company information
About Glucose Health
Glucose Health, Inc. is a consumer health company focused on nutritional products designed to support healthy blood sugar levels. Its principal product is Glucose Health® Blood Sugar Support Drink Mix, a powdered beverage marketed for people seeking a convenient addition to their daily wellness routine. The company’s product is positioned as nutritional support, not as a treatment for diabetes or other medical conditions.
See Also
- Five stocks we like better than Glucose Health
- 5 Consumer Discretionary Plays Showing Strength During the Tech Sell-Off
- NVIDIA’s Earnings Were Strong, But Can the Next CEO Keep the Momentum Going?
- SpaceX’s Historic Starship Catch Raises a Bigger Question About Its AI Spending
- AMD Bets $8.2B on Physical AI: Could Robotics Be Its Next Growth Frontier?
Receive News & Ratings for Glucose Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glucose Health and related companies with MarketBeat.com's FREE daily email newsletter.
